Drugs / Easy Five
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT00674908 Comparator | Mar 2008 → Mar 2009 | diphtheria, haemophilus infectious disease, hepatitis B virus infection, pertussis +1 | Shantha Biotechnics Limited | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Easy Five | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00674908 ↗ |
| Modality | Vaccine | “Diphtheria, tetanus, whole cell pertussis, recombinant hepatitis B and Hib conjugate pentavalent liquid combination vaccine” NCT00674908 ↗ |